Financhill
Sell
44

AMP Quote, Financials, Valuation and Earnings

Last price:
$515.19
Seasonality move :
2.01%
Day range:
$514.40 - $528.49
52-week range:
$368.41 - $577.00
Dividend yield:
1.08%
P/E ratio:
20.53x
P/S ratio:
3.32x
P/B ratio:
9.08x
Volume:
539.9K
Avg. volume:
452.6K
1-year change:
36.37%
Market cap:
$51.9B
Revenue:
$15.5B
EPS (TTM):
$26.05

AMP Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for Ameriprise Financial shares anticipate an average target of $559.73, ranging from a low estimate of $415.00 to a high estimate of $655.00. This average target implies a growth of 4.64% compared to the current stock price of $534.93.

Consensus Price Target

$559.73

Highest Price Target

$655.00

Lowest Price Target

$415.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 5 4

Hold 6 7 8

Sell 0 0 0
Consensus Hold Hold Hold

AMP Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 11

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock